Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jan 12:12:836119.
doi: 10.3389/fimmu.2021.836119. eCollection 2021.

Editorial: Recent Advances in Potential Biomarkers for Rheumatic Diseases and in Cell-Based Therapies in the Management of Inflammatory Rheumatic Diseases

Philippe Saas  1   2 , Eric Toussirot  1   2   3   4   5 , Katarzyna Bogunia-Kubik  6
Affiliations
Editorial

Editorial: Recent Advances in Potential Biomarkers for Rheumatic Diseases and in Cell-Based Therapies in the Management of Inflammatory Rheumatic Diseases

Philippe Saas et al. Front Immunol. .
No abstract available

Keywords: TNF inhibitors; biomarkers; cell-based therapy; inflammatory rheumatic diseases; psoriatic arthritis; rheumatoid arthritis; spondyloarthritis; systemic lupus erythematosus.

PubMed Disclaimer

Conflict of interest statement

PS is the author of a patent and a shareholder of Med’Inn’Pharma, related to the development of anti-inflammatory treatment. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Recent Advances in Potential Biomarkers for Rheumatic Diseases and in Cell-based Therapies in the Management of Inflammatory Rheumatic Diseases

References

    1. Buch MH, Eyre S, McGonagle D. Persistent Inflammatory and non-Inflammatory Mechanisms in Refractory Rheumatoid Arthritis. Nat Rev Rheumatol (2021) 17:17–33. doi: 10.1038/s41584-020-00541-7 - DOI - PubMed
    1. Radner H, Smolen JS, Aletaha D. Remission in Rheumatoid Arthritis: Benefit Over Low Disease Activity in Patient-Reported Outcomes and Costs. Arthritis Res Ther (2014) 16:R56. doi: 10.1186/ar4491 - DOI - PMC - PubMed
    1. Curtis JR, van der Helm-van Mil AH, Knevel R, Huizinga TW, Haney DJ, Shen Y, et al. . Validation of a Novel Multibiomarker Test to Assess Rheumatoid Arthritis Disease Activity. Arthritis Care Res (2012) 64:1794–803. doi: 10.1002/acr.21767 - DOI - PMC - PubMed
    1. Hambardzumyan K, Bolce R, Saevarsdottir S, Cruickshank SE, Sasso EH, Chernoff D, et al. . Pretreatment Multi-Biomarker Disease Activity Score and Radiographic Progression in Early RA: Results From the SWEFOT Trial. Ann Rheum Dis (2015) 74:1102–9. doi: 10.1136/annrheumdis-2013-204986 - DOI - PMC - PubMed
    1. Williams RO, Feldmann M, Maini RN. Anti-Tumor Necrosis Factor Ameliorates Joint Disease in Murine Collagen-Induced Arthritis. Proc Natl Acad Sci USA (1992) 89:9784–8. doi: 10.1073/pnas.89.20.9784 - DOI - PMC - PubMed

Publication types

LinkOut - more resources